Reduction in lipopolysaccharide-induced apoptosis of fibroblasts obtained from a patient with gingival overgrowth during nifedipine-treatment

Arch Oral Biol. 2011 Oct;56(10):1073-80. doi: 10.1016/j.archoralbio.2011.03.006. Epub 2011 Apr 6.

Abstract

Objective: We have previously demonstrated that the mechanism of nifedipine (NIF)-induced gingival overgrowth is related to the observation that proliferation and cell cycle progression of gingival fibroblasts derived from NIF reactive patient (NIFr) are greater than those from NIF non-reactive patient (NIFn). Gingival overgrowth has also been reported to be a result of inhibited apoptosis of gingival fibroblasts. Apoptosis in fibroblasts is induced by lipopolysaccharide (LPS). Thus, we focused upon evaluating whether there is a difference in LPS-induced apoptosis between NIFn and NIFr.

Methods: Both NIFn and NIFr were arrested in DMEM containing 0.5% FBS, stimulated by LPS, and assayed for apoptosis, cell cycle analysis, Western blotting, and caspase activity.

Results: Compared to NIFn, the number of apoptotic cells was significantly decreased and the percentage of cells in S and G(2)/M phase was significantly increased in NIFr. The levels of Bax and cytochrome c proteins in NIFr were not up-regulated by LPS compared with NIFn. Both NIFn and NIFr displayed the following changes in protein expression: increased Bad, decreased Bcl-xL, and unchanged Bcl-2 and p53. Caspase-3 and -9 activities were significantly increased by LPS in NIFn but were unchanged in NIFr. Caspase-2 activity remained constant whilst caspase-8 activity significantly increased upon LPS treatment in both NIFn and NIFr.

Conclusion: Bad, Bax, cytochrome c, p53, and caspases-2, -3, -8, and -9 are pro-apoptotic proteins. Bcl-2 and Bcl-xL are anti-apoptotic proteins. Thus, the mechanism of NIF-induced gingival overgrowth might be related to decreased apoptosis in NIFr through a reduction of Bax, cytochrome c, and caspase-3 and -9.

Publication types

  • Comparative Study

MeSH terms

  • Apoptosis / drug effects*
  • Caspase 2 / analysis
  • Caspase 2 / drug effects
  • Caspase 3 / analysis
  • Caspase 3 / drug effects
  • Caspase 8 / analysis
  • Caspase 8 / drug effects
  • Caspase 9 / analysis
  • Caspase 9 / drug effects
  • Cell Culture Techniques
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Cysteine Endopeptidases / analysis
  • Cysteine Endopeptidases / drug effects
  • Cytochromes c / analysis
  • Cytochromes c / drug effects
  • Escherichia coli
  • Fibroblasts / drug effects*
  • G2 Phase / drug effects
  • Gingiva / drug effects*
  • Gingiva / pathology
  • Gingival Overgrowth / chemically induced
  • Gingival Overgrowth / pathology*
  • Humans
  • Lipopolysaccharides / pharmacology*
  • Metaphase / drug effects
  • Nifedipine / adverse effects*
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Proto-Oncogene Proteins c-bcl-2 / drug effects
  • S Phase / drug effects
  • Tumor Suppressor Protein p53 / analysis
  • Tumor Suppressor Protein p53 / drug effects
  • Vasodilator Agents / adverse effects*
  • bcl-2-Associated X Protein / analysis
  • bcl-2-Associated X Protein / drug effects
  • bcl-Associated Death Protein / analysis
  • bcl-Associated Death Protein / drug effects
  • bcl-X Protein / analysis
  • bcl-X Protein / drug effects

Substances

  • BAD protein, human
  • BAX protein, human
  • BCL2L1 protein, human
  • Lipopolysaccharides
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • Vasodilator Agents
  • bcl-2-Associated X Protein
  • bcl-Associated Death Protein
  • bcl-X Protein
  • Cytochromes c
  • CASP2 protein, human
  • CASP8 protein, human
  • Caspase 2
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Cysteine Endopeptidases
  • Nifedipine